Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Tech Coloproctol ; 27(12): 1297-1305, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-37486461

RESUMEN

BACKGROUND: The optimal treatment of colorectal cancer is surgical resection and primary anastomosis. Anastomotic leak can affect up to 20% of patients and creates significant morbidity and mortality. Current diagnosis of a leak is based on clinical suspicion and subsequent radiology. Peritoneal biomarkers have shown diagnostic utility in other conditions and could be useful in providing earlier diagnosis. This pilot study was designed to assess the practical utility of peritoneal biomarkers after abdominal surgery utilising an automated immunoassay system in routine use for quantifying cytokines. METHODS: Patients undergoing an anterior resection for a rectal cancer diagnosis were recruited at University Hospital of Wales, Cardiff between June 2019 and June 2021. A peritoneal drain was placed in the proximity of the anastomosis during surgery, and peritoneal fluid was collected at days 1 to 3 post-operatively, and analysed using the Siemens IMMULITE platform for interleukin (IL)-1ß, IL-6, IL-10, CXCL8, tumour necrosis factor alpha (TNFα) and C-reactive protein (CRP). RESULTS: A total of 42 patients were recruited (22M:20F, median age 65). Anastomotic leak was detected in four patients and a further five patients had other intra-abdominal complications. The IMMULITE platform was able to provide robust and reliable results from the analysis of the peritoneal fluid. A metric based on the combination of peritoneal IL-6 and CRP levels was able to accurately diagnose three anastomotic leaks, whilst correctly classifying all negative control patients including those with other complications. CONCLUSIONS: This pilot study demonstrates that a simple immune signature in surgical drain fluid could accurately diagnose an anastomotic leak at 48 h postoperatively using instrumentation that is already widely available in hospital clinical laboratories.


Asunto(s)
Fuga Anastomótica , Neoplasias del Recto , Humanos , Anciano , Fuga Anastomótica/diagnóstico , Fuga Anastomótica/etiología , Interleucina-6 , Proyectos Piloto , Biomarcadores , Anastomosis Quirúrgica/efectos adversos , Neoplasias del Recto/complicaciones , Estudios Retrospectivos
2.
Clin Exp Immunol ; 161(2): 290-7, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20491785

RESUMEN

The potent anti-tumour activities of gammadelta T cells have prompted the development of protocols in which gammadelta-agonists are administered to cancer patients. Encouraging results from small Phase I trials have fuelled efforts to characterize more clearly the application of this approach to unmet clinical needs such as metastatic carcinoma. To examine this approach in breast cancer, a Phase I trial was conducted in which zoledronate, a Vgamma9Vdelta2 T cell agonist, plus low-dose interleukin (IL)-2 were administered to 10 therapeutically terminal, advanced metastatic breast cancer patients. Treatment was well tolerated and promoted the effector maturation of Vgamma9Vdelta2 T cells in all patients. However, a statistically significant correlation of clinical outcome with peripheral Vgamma9Vdelta2 T cell numbers emerged, as seven patients who failed to sustain Vgamma9Vdelta2 T cells showed progressive clinical deterioration, while three patients who sustained robust peripheral Vgamma9Vdelta2 cell populations showed declining CA15-3 levels and displayed one instance of partial remission and two of stable disease, respectively. In the context of an earlier trial in prostate cancer, these data emphasize the strong linkage of Vgamma9Vdelta2 T cell status to reduced carcinoma progression, and suggest that zoledronate plus low-dose IL-2 offers a novel, safe and feasible approach to enhance this in a subset of treatment-refractory patients with advanced breast cancer.


Asunto(s)
Neoplasias de la Mama/terapia , Difosfonatos/uso terapéutico , Imidazoles/uso terapéutico , Inmunoterapia/métodos , Interleucina-2/uso terapéutico , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Subgrupos de Linfocitos T/citología , Adyuvantes Inmunológicos/efectos adversos , Adyuvantes Inmunológicos/farmacología , Adyuvantes Inmunológicos/uso terapéutico , Anciano , Neoplasias de la Mama/sangre , Neoplasias de la Mama/inmunología , Proliferación Celular/efectos de los fármacos , Quimiocinas/sangre , Citocinas/sangre , Difosfonatos/efectos adversos , Difosfonatos/farmacología , Progresión de la Enfermedad , Esterasas/metabolismo , Femenino , Hemiterpenos/farmacología , Humanos , Imidazoles/efectos adversos , Imidazoles/farmacología , Interferón gamma/metabolismo , Interleucina-2/efectos adversos , Interleucina-2/farmacología , Antígenos Comunes de Leucocito/metabolismo , Activación de Linfocitos/efectos de los fármacos , Recuento de Linfocitos , Lisina/análogos & derivados , Lisina/metabolismo , Persona de Mediana Edad , Mucina-1/sangre , Compuestos Organofosforados/farmacología , Inducción de Remisión , Terapia Recuperativa , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Ligando Inductor de Apoptosis Relacionado con TNF/metabolismo , Resultado del Tratamiento , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/metabolismo , Ácido Zoledrónico
3.
Science ; 285(5433): 1573-6, 1999 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-10477522

RESUMEN

A mevalonate-independent pathway of isoprenoid biosynthesis present in Plasmodium falciparum was shown to represent an effective target for chemotherapy of malaria. This pathway includes 1-deoxy-D-xylulose 5-phosphate (DOXP) as a key metabolite. The presence of two genes encoding the enzymes DOXP synthase and DOXP reductoisomerase suggests that isoprenoid biosynthesis in P. falciparum depends on the DOXP pathway. This pathway is probably located in the apicoplast. The recombinant P. falciparum DOXP reductoisomerase was inhibited by fosmidomycin and its derivative, FR-900098. Both drugs suppressed the in vitro growth of multidrug-resistant P. falciparum strains. After therapy with these drugs, mice infected with the rodent malaria parasite P. vinckei were cured.


Asunto(s)
Isomerasas Aldosa-Cetosa/antagonistas & inhibidores , Antimaláricos/farmacología , Fosfomicina/análogos & derivados , Hemiterpenos , Malaria/tratamiento farmacológico , Complejos Multienzimáticos/antagonistas & inhibidores , Oxidorreductasas/antagonistas & inhibidores , Pentosafosfatos/metabolismo , Plasmodium falciparum/efectos de los fármacos , Terpenos/farmacología , Isomerasas Aldosa-Cetosa/química , Isomerasas Aldosa-Cetosa/genética , Isomerasas Aldosa-Cetosa/metabolismo , Secuencia de Aminoácidos , Animales , Clonación Molecular , Inhibidores Enzimáticos/farmacología , Fosfomicina/farmacología , Genes Protozoarios , Malaria/parasitología , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/parasitología , Ácido Mevalónico/metabolismo , Ratones , Datos de Secuencia Molecular , Complejos Multienzimáticos/química , Complejos Multienzimáticos/genética , Complejos Multienzimáticos/metabolismo , Orgánulos/efectos de los fármacos , Orgánulos/metabolismo , Compuestos Organofosforados/metabolismo , Oxidorreductasas/química , Oxidorreductasas/genética , Oxidorreductasas/metabolismo , Plasmodium falciparum/genética , Plasmodium falciparum/metabolismo , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
4.
Med Klin Intensivmed Notfmed ; 113(7): 574-576, 2018 10.
Artículo en Alemán | MEDLINE | ID: mdl-29236129

RESUMEN

The unintentional poisoning with aconite in a 32-year-old healthy woman led to life-threatening neurological and cardiovascular effects with cardiac arrest and need for resuscitation. The combined administration of magnesium and amiodarone was able to stabilize heart rhythm and circulation. Organ damage was not recognized in the follow-up.


Asunto(s)
Aconitum , Paro Cardíaco , Intoxicación , Aconitum/química , Aconitum/envenenamiento , Adulto , Amiodarona/uso terapéutico , Femenino , Paro Cardíaco/inducido químicamente , Humanos , Intoxicación/etiología , Intoxicación/terapia , Bloqueadores de los Canales de Potasio/uso terapéutico , Resucitación
5.
FEBS Lett ; 499(1-2): 37-40, 2001 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-11418107

RESUMEN

The mevalonate-independent 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis is essential in many eubacteria, plants, and the malaria parasite. Using genetically engineered Escherichia coli cells able to utilize exogenously provided mevalonate for isoprenoid biosynthesis by the mevalonate pathway we demonstrate that the lytB gene is involved in the trunk line of the MEP pathway. Cells deleted for the essential lytB gene were viable only if the medium was supplemented with mevalonate or the cells were complemented with an episomal copy of lytB.


Asunto(s)
Proteínas Bacterianas/metabolismo , Eritritol/metabolismo , Proteínas de Escherichia coli , Escherichia coli/metabolismo , Ácido Mevalónico/metabolismo , Oxidorreductasas , Fosfatos de Poliisoprenilo/biosíntesis , Fosfatos de Azúcar/metabolismo , Animales , Proteínas Bacterianas/genética , Eritritol/análogos & derivados , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Eliminación de Gen , Genes Bacterianos/genética , Genes Esenciales/genética , Prueba de Complementación Genética , Humanos , Fosfatos de Poliisoprenilo/metabolismo , Homología de Secuencia
6.
FEBS Lett ; 509(2): 317-22, 2001 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-11741609

RESUMEN

The gcpE and lytB gene products control the terminal steps of isoprenoid biosynthesis via the 2-C-methyl-D-erythritol 4-phosphate pathway in Escherichia coli. In lytB-deficient mutants, a highly immunogenic compound accumulates significantly, compared to wild-type E. coli, but is apparently absent in gcpE-deficient mutants. Here, this compound was purified from E. coli DeltalytB mutants by preparative anion exchange chromatography, and identified by mass spectrometry, (1)H, (13)C and (31)P NMR spectroscopy, and NOESY analysis as (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP). HMB-PP is 10(4) times more potent in activating human Vgamma9/Vdelta2 T cells than isopentenyl pyrophosphate.


Asunto(s)
Difosfatos/farmacología , Enzimas , Eritritol/análogos & derivados , Proteínas de Escherichia coli , Escherichia coli/química , Activación de Linfocitos/efectos de los fármacos , Mitógenos/farmacología , Oxidorreductasas , Receptores de Antígenos de Linfocitos T gamma-delta , Subgrupos de Linfocitos T/efectos de los fármacos , Proteínas Bacterianas/genética , Difosfatos/química , Eritritol/biosíntesis , Humanos , Mitógenos/química , Modelos Biológicos , Resonancia Magnética Nuclear Biomolecular , Espectrometría de Masa por Ionización de Electrospray , Fosfatos de Azúcar/biosíntesis , Terpenos/metabolismo
7.
J Cancer Res Clin Oncol ; 110(2): 141-4, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-2995397

RESUMEN

Biochemical determination of hormone receptors in carcinomas is influenced by the potential heterogeneity of the tissue samples. In order to check this, samples of 16 breast cancers were divided into 6 segments. These segments were alternately examined for their ratio of tumor tissue to connective tissue ("percentage of carcinoma") or for the content of estrogen and progesterone receptors. Only 3 of the tumors were homogeneous, and 9 of the heterogeneous tissues had hormone receptors. The segment with the maximum "percentage of carcinoma" was adjacent to that with the peak value of hormone receptors in all but 1 tissue. The same applied to the minima. The maximum and minimum values of estrogen and progesterone receptors were located within the same segment in all but one tissue sample. The results demonstrated that biochemical assay of hormone receptors is reliable. A reduction of the sample volume does not enhance the precision of the receptor assay, since it increases the possibility of a false negative result.


Asunto(s)
Adenocarcinoma Mucinoso/metabolismo , Neoplasias de la Mama/metabolismo , Carcinoma Intraductal no Infiltrante/metabolismo , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Adenocarcinoma Mucinoso/patología , Neoplasias de la Mama/patología , Carcinoma Intraductal no Infiltrante/patología , Femenino , Humanos
8.
Pathol Res Pract ; 169(2): 165-72, 1980 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-7443573

RESUMEN

Sixty-nine cases of uterine sarcoma were reviewed histologically withhh respect to their grade of malignancy. Mitotic activity is the most important criterion of malignancy. A histological grading was performed on the basis of mitotic counts per high power field. Clinical follow-up showed that except for the local extension of the tumor, the prognosis of sarcomas depends greatly on mitotic activity. There is a good correlation in the lower stages I and II between number of mitoses and survival rate. The 5 year survival rate of patients with grades I or II is 77% compared to 41% for grades III and IV. Vascular invasion is not evident in distant metastases in our material. Adjuvant chemotherapy is recommended in clinical stages II-IV and in histological grades III and IV.


Asunto(s)
Sarcoma/patología , Neoplasias Uterinas/patología , Femenino , Estudios de Seguimiento , Humanos , Leiomiosarcoma/patología , Mitosis , Metástasis de la Neoplasia , Estadificación de Neoplasias , Pronóstico , Sarcoma/mortalidad , Sarcoma/terapia , Neoplasias Uterinas/mortalidad , Neoplasias Uterinas/terapia
9.
Pathol Res Pract ; 169(2): 173-8, 1980 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-7443574

RESUMEN

216 sarcomas of the female genitalia were treated at the University hospitals for women of Freiburg and Tübingen between the years 1957 to 1977. 76% originated from the uterine corpus; 28% (46/164) of the sarcomas of the corpus uteri were detected as incidental findings. The 5 year survival rates is 54% in stage I, 25% in stage II, and 40% in all stages (52/131). Postoperative irradiation of stage I cases of sarcomas of the corpus uteri diminished local recurrence but not metastases. Extirpation of the ovaries has no influence on local recurrence. Sarcomas of the vulva and cervix have a comparatively good prognosis, whereas the prognosis of the sarcoma of the ovary is very bad. The bad prognosis of sarcomas of the female genitalia points out the necessity of developing cooperative clinical trials on the effectiveness of adjuvant chemotherapy.


Asunto(s)
Sarcoma/terapia , Neoplasias del Cuello Uterino/terapia , Neoplasias Uterinas/terapia , Neoplasias de la Vulva/terapia , Femenino , Estudios de Seguimiento , Humanos , Estadificación de Neoplasias , Pronóstico , Remisión Espontánea , Sarcoma/patología , Neoplasias del Cuello Uterino/patología , Neoplasias Uterinas/patología , Neoplasias de la Vulva/patología
10.
J Cardiovasc Surg (Torino) ; 29(6): 670-5, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3264836

RESUMEN

Single Photon Emission Computed Tomography (SPECT), imaging of cerebral blood flow was carried out in ten patients with haemodynamically significant carotid stenosis. Before and after carotid endarterectomy each patient was investigated by 3--dimensional SPECT brain scanning using technetium--hexamethyl propyleneamine oxine (99 mTcHMPAO, ceretec). Brain blood flow was normal before and after operation in 3 patients whose autoregulation was kept intact. Seven patients received acetazolamide to limit cerebral vascular reactivity and in four of these, preoperative perfusion defects were visible. After carotid endarterectomy the ipsilateral perfusion defects were abolished and it is concluded that carotid stenosis can reduce perfusion in the dysautoregulation brain and that carotid reconstruction can restore normal flow.


Asunto(s)
Arteriopatías Oclusivas/diagnóstico por imagen , Enfermedades de las Arterias Carótidas/diagnóstico por imagen , Circulación Cerebrovascular , Tomografía Computarizada de Emisión , Acetazolamida/farmacología , Anciano , Arteriopatías Oclusivas/complicaciones , Arteriopatías Oclusivas/fisiopatología , Enfermedades de las Arterias Carótidas/complicaciones , Enfermedades de las Arterias Carótidas/fisiopatología , Circulación Cerebrovascular/efectos de los fármacos , Femenino , Homeostasis , Humanos , Ataque Isquémico Transitorio/diagnóstico por imagen , Ataque Isquémico Transitorio/etiología , Ataque Isquémico Transitorio/cirugía , Masculino , Persona de Mediana Edad
11.
Complement Ther Med ; 10(4): 229-34, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12594974

RESUMEN

INTRODUCTION: Phytic acid or IP6 has been extensively studied in animals and is being promoted as an anti-cancer agent in health food stores. It is naturally found in legumes, wheat bran, and soy foods. It is believed to be the active ingredient that gives these substances their cancer fighting abilities. Proposed mechanisms of action include gene alteration, enhanced immunity, and anti-oxidant properties. METHODS: A Medline search from 1966 to May 2002 using the keywords phytic acid and cancer, and limiting the search to the subheadings of therapeutic uses, prevention, and adverse effects revealed 28 studies. These studies were included in the review. RESULTS: A great majority of the studies were done in animals and showed that phytic acid had anti-neoplastic properties in breast, colon, liver, leukemia, prostate, sarcomas, and skin cancer. There were no human studies. Side effects included chelation of multivalent cations, and an increase in bladder and renal papillomas. This increase in papilloma formation only occurred with the sodium salt of phytic acid. It did not occur with either the potassium or magnesium salts. CONCLUSIONS: There is a large body of animal evidence to show that phytic acid may have a role in both the prevention and treatment of many forms of cancer. There is clearly enough evidence to justify the initiation of Phase I and Phase II clinical trials in humans.


Asunto(s)
Antineoplásicos/farmacología , Ácido Fítico/farmacología , Animales
12.
Prikl Biokhim Mikrobiol ; 39(5): 565-70, 2003.
Artículo en Ruso | MEDLINE | ID: mdl-14593871

RESUMEN

Extraction and purification from the biomass of Corynebacterium ammoniagenes of 2-C-methyl-D-erhythritol 2,4-cyclopyrophosphate (MEC) was associated with its spontaneous transformation into a number of derivatives (which was due to pyrophosphate bond lability and the formation of complexes with metals). These derivatives included 1,2-cyclophospho-4-phosphate, 2,4-diphosphate, 2,3-cyclophosphate, 1,4-diphosphate, and 3,5-diphosphate (identified by 1H, 31P, and 13C NMR spectroscopy) and accounted for about 10% MEC. When added to a solution of DNA in the presence of the Fenton reagent, MEC prevented DNA decomposition. In addition, MEC slowed down the interaction of the reagent with tempol radicals, which indicates that complexation of ferrous ions by MEC attenuates their ability to catalyze the formation of hydroxyl radicals from hydrogen peroxide. In the presence of 0.23 mM MEC, the rate of respiration of rat liver mitochondria increased 1.8 times. At 0.1-1.0 mM, MEC activated in vitro proliferation of human Vgamma9 T-cells. It is suggested that MEC acts as an endogenous stabilizing agent for bacterial cells subjected to oxidative stress and as an immunomodulator for eukaryotic hosts.


Asunto(s)
Corynebacterium/metabolismo , Eritritol/análogos & derivados , Eritritol/aislamiento & purificación , Terpenos/metabolismo , Adyuvantes Inmunológicos/farmacología , Animales , División Celular/efectos de los fármacos , Células Cultivadas , Óxidos N-Cíclicos/metabolismo , ADN/metabolismo , Relación Dosis-Respuesta a Droga , Eritritol/química , Eritritol/farmacología , Compuestos Ferrosos , Humanos , Peróxido de Hidrógeno/metabolismo , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Estrés Oxidativo , Plásmidos , Ratas , Marcadores de Spin , Linfocitos T/efectos de los fármacos
13.
Oncogene ; 30(44): 4523-30, 2011 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-21577203

RESUMEN

CYLD is a deubiquitination enzyme that regulates different cellular processes, such as cell proliferation and cell survival. Mutation and loss of heterozygosity of the CYLD gene causes development of cylindromatosis, a benign tumour originating from the skin. Our study shows that CYLD expression is dramatically downregulated in basal cell carcinoma (BCC), the most common cancer in humans. Reduced CYLD expression in basal cell carcinoma was mediated by GLI1-dependent activation of the transcriptional repressor Snail. Inhibition of GLI1 restored the CYLD expression-mediated Snail signaling pathway, and caused a significant delay in the G1 to S phase transition, as well as proliferation. Our data suggest that GLI1-mediated suppression of CYLD has a significant role in basal cell carcinoma progression.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , Factores de Transcripción/genética , Proteínas Supresoras de Tumor/genética , Carcinoma Basocelular/genética , Ciclo Celular , Línea Celular Tumoral , Proliferación Celular , Enzima Desubiquitinante CYLD , Humanos , Neoplasias Cutáneas/genética , Factores de Transcripción de la Familia Snail , Proteína con Dedos de Zinc GLI1
15.
Infect Immun ; 67(7): 3383-9, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10377116

RESUMEN

We present here a novel approach to identify T-cell antigens from any infectious agent by use of a library of purified recombinant proteins. Essential features of this strategy include (i) a highly efficient cDNA cloning system which negatively selects against nonrecombinant transformants by making use of the bacterial EcoK restriction system, (ii) affinity staining of cDNA clones expressing recombinant proteins, and (iii) a procedure of simultaneous purification of recombinant proteins from large numbers of isolated clones (representing the protein library) in a single step from pools consisting of up to 24 individual clones. The feasibility of the screening system was confirmed by constructing a protein library of the human parasite Schistosoma mansoni. The recombinant antigens of this library were used to stimulate CD4(+) T cells derived from the axillary lymph nodes of mice vaccinated with irradiated cercariae. In initial screening experiments, we detected parasite-specific proliferation and gamma interferon (IFN-gamma) secretion in response to several pools of cDNA clones. Further analysis of one particular pool revealed that only one of its constituents stimulated considerable IFN-gamma secretion by CD4(+) T cells and that the expressed antigen is identical to a small fragment of myosin heavy chain.


Asunto(s)
Antígenos Helmínticos/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/inmunología , Linfocitos T/inmunología , Vacunas/inmunología , Animales , Presentación de Antígeno , Citotoxicidad Inmunológica , Humanos , Ratones , Biblioteca de Péptidos , Receptores de Antígenos de Linfocitos T/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Vacunas/genética
16.
Geburtshilfe Frauenheilkd ; 39(3): 239-42, 1979 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-437459

RESUMEN

In 13 patients with abortion in the second to fourth months of pregnancy the variation in oestrogen levels in the plasma was determined before and after abrasion of the abortus, using the radioimmunoassay method, and correlated with the results of histological examination of the abraded parts. Seven women without endometritis revealed high oestrogen concentrations before and after the abrasion (mean (1734 pg/ml or 397 pg/ml, respectively). On the fifth day after abrasion the levels corresponded with those of the proliferation phase of the normal menstrual cycle (mean 115 pg/ml). In six women with histologically established endometritis low oestrogen levels were found before and after the abrasion, the mean values being 101 pg/ml and 36 pg/ml, respectively. On the fifth day the values continued to remain low (average 25 pg/ml). The difference in oestrogen concentrations of both groups was significant and correlated well with the results of histological examination of the abraded parts.


PIP: Curettage was performed in 13 women who had had spontaneous abortions, and the abraded material was tested for signs of endometritis. Plasma estrogen levels were also taken for several days following the curettage. In the group of 7 women without endometritis, uterine bleeding generally lasted up to 1 day following curettage. Estrogen levels were relatively high, average 1734 pg/ml, but fell to 64-70 pg/ml on the 3rd and 4th days, after which the estrogen levels continued to rise. The 6 women with endometritis had been treated for incomplete abortion in the 3rd month. Uterine bleeding generally lasted 1-2 days after the currettage. Plasma estrogen levels were 101 pg/ml at the time of the curettage and fell continually afterwards; no increase in the estrogen levels on the 4th-5th days after curettage was observed. The estrogen concentrations of the patients without endometritis were significantly higher than those of the endometritis group before and on the first and fifth days after the abortion.


Asunto(s)
Aborto Espontáneo/complicaciones , Endometritis/sangre , Estrógenos/sangre , Biopsia , Decidua/patología , Femenino , Humanos , Embarazo , Factores de Tiempo
17.
Reproduction ; 121(4): 595-603, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11277880

RESUMEN

A questionnaire assessing factors that might cause an increase in scrotal temperature was completed by patients with reproducible oligoasthenoteratozoospermia of idiopathic nature or caused by varicocele. Evaluation by means of a grading scale revealed increased scrotal heat stress in oligoasthenoteratozoospermic patients compared with normozoospermic men (P < 0.01). In addition, long-term determination of 24 h scrotal temperature profiles showed that compared with semen donors, oligoasthenoteratozoospermic patients frequently had scrotal temperatures above 35.5 degrees C despite the same environmental temperatures (P < 0.05). In 88% of cases, maximum scrotal temperatures were measured during rest or sleep phases, whereas minimum values were recorded during physical activity or frequent change of position. Nocturnal scrotal cooling by means of an air stream resulted in a decrease in scrotal temperature of approximately 1 degrees C. Furthermore, a highly significant increase in sperm concentration (P < 0.0001) and total sperm output (P < 0.0001) was achieved after nocturnal scrotal cooling for 12 weeks together with a moderate decrease in factors leading to genital heat stress. A significant improvement in sperm motility (P < 0.05) and sperm morphology (P < 0.05) was also observed, but this improvement was markedly less pronounced than the changes in sperm concentration. This study shows the importance of genital heat stress as a cofactor in fertility impairment in men and indicates nocturnal scrotal cooling as a therapeutic option.


Asunto(s)
Terapia Conductista , Frío , Genitales Masculinos/fisiopatología , Trastornos de Estrés por Calor , Infertilidad Masculina/terapia , Escroto/fisiopatología , Semen/fisiología , Temperatura Corporal , Equipos y Suministros , Hormona Folículo Estimulante/sangre , Humanos , Infertilidad Masculina/etiología , Infertilidad Masculina/fisiopatología , Hormona Luteinizante/sangre , Masculino , Oligospermia/etiología , Oligospermia/fisiopatología , Recuento de Espermatozoides , Motilidad Espermática , Espermatogénesis , Espermatozoides/anomalías , Encuestas y Cuestionarios , Testosterona/sangre , Varicocele/complicaciones
18.
Andrologia ; 32(4-5): 303-10, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11021523

RESUMEN

Hydrogen hexachloroplatinate, H2PtCl6, has been shown to induce the human sperm acrosome reaction in vitro. However, the molecular mechanism underlying this exocytic process has not been studied. Therefore, two structurally and chemically different platinum (Pt) compounds, the potent sensitizer sodium-hexachloro-platinate-(IV), Na2[PtCl6], and the nonimmunogenic tetraamineplatinum-(II)-chloride, [Pt(NH3)4]Cl2, were selected for the experiments. Their effects on human sperm function and second messenger pathways were investigated. Washed human spermatozoa were treated with different concentrations of both Pt salts (0.5-1000 microM) during or after capacitation for 3 h at 37 degrees C. In addition, spermatozoa were incubated with Pt salts in calcium-free medium or in the presence of the protein kinase A+C inhibitor H7. Sperm motility was evaluated by computer-assisted sperm analysis; acrosomal loss was detected by triple staining. Compared with the controls (6.6+/-2.4%), the percentages of living acrosome-reacted spermatozoa showed a significant dose-dependent increase (P<0.001) after 3 h of incubation with Na2[PtCl6] (7.9+/-4.2% for 0.5 microM 25.0+/-2.9% for 1 mM) and [Pt(NH3)4]Cl2 (7.9+/-3.9% to 21.0+/-5.8%). Sperm motility was markedly reduced in samples containing the highest concentrations of the Pt salts. The acrosome reaction was also significantly increased when spermatozoa had first been capacitated and then treated with both Pt salts. Calcium-free medium had no effect on the ability of both Pt salts to induce the acrosome reaction. However, incubation of Na2[PtCl6] in the presence of H7 tendentiously decreased the percentage of acrosome-reacted spermatozoa. In conclusion, complex Pt salts such as Na2[PtCl6] or [Pt(NH3)4]Cl2 influence human sperm functions by inducing the acrosome reaction during or after capacitation. This stimulatory effect is independent of calcium and seems to be dependent on protein kinase A or C.


Asunto(s)
Reacción Acrosómica/efectos de los fármacos , Cisplatino/análogos & derivados , Compuestos de Nitrógeno/toxicidad , Compuestos de Platino/toxicidad , Motilidad Espermática/efectos de los fármacos , Cisplatino/toxicidad , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Humanos , Técnicas In Vitro , Masculino , Proteína Quinasa C/antagonistas & inhibidores , Sistemas de Mensajero Secundario/efectos de los fármacos , Capacitación Espermática/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Espermatozoides/fisiología
19.
Vaccine ; 18(19): 2002-8, 2000 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-10706961

RESUMEN

Due to the synergistic effects of IL-12 and IL-18, and to their importance in establishing a Th1 type immune response, we investigated the potential of a combined administration of both cytokines as an adjuvant for recombinant antigens. As a model system, we used a schistosome T cell antigen recently identified in our group. By co-adsorption of this antigen on alum in the presence of IL-12 and IL-18, we demonstrate that IL-18 enhances the effects of IL-12 in inducing an antigen-specific Th1 type CD4(+) T cell response as well as high titres of IgG1, IgG2a, and IgG2b antibodies.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Antígenos/administración & dosificación , Interleucina-12/administración & dosificación , Interleucina-18/administración & dosificación , Células TH1/efectos de los fármacos , Células TH1/inmunología , Animales , Anticuerpos Antihelmínticos/biosíntesis , Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos/administración & dosificación , Sinergismo Farmacológico , Femenino , Proteínas del Helminto/administración & dosificación , Proteínas del Helminto/inmunología , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/sangre , Ratones , Ratones Endogámicos C57BL , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/inmunología , Schistosoma mansoni/inmunología
20.
Parasite Immunol ; 23(3): 141-52, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11240905

RESUMEN

Calreticulin was recently identified as a hookworm (Necator americanus) allergen, implying secretion, and contact with cells of the immune system, or significant worm attrition in the tissues of the host. As human calreticulin has been shown to bind to and neutralize the haemolytic activity of the complement component C1q, and to be putatively involved in integrin-mediated intracellular signalling events in platelets, it was of interest to determine whether a calreticulin from a successful nematode parasite of humans, with known immune modulatory and antihaemostatic properties, exhibited a capacity to interfere with complement activation and to interact with integrin domains associated with cell signalling in platelets and other leucocytes. We can now report that recombinant calreticulin failed to demonstrate significant calcium binding capacity, which is a hallmark of calreticulins in general and may indicate inappropriate folding following expression in a prokaryote. Nevertheless, recombinant calreticulin retained sufficient molecular architecture to bind to, and inhibit the haemolytic capacity of, human C1q. Furthermore, recombinant calreticulin reacted in surface plasmon resonance analysis (SPR) with peptides corresponding to cytoplasmic signalling domains of the integrins alphaIIb and alpha5, in a calcium independent manner. SPR was also used to ratify the specificity of a polyclonal antibody to hookworm calreticulin, which was then used to assess the stage specificity of expression of the native molecule (in comparison with reverse transcriptase-polymerase chain reaction), to indicate its apparent secretion, and to purify native calreticulin from worm extracts by affinity chromatography. This development will allow the functional tests described above to be repeated for native calreticulin, to ascertain its role in the host-parasite relationship.


Asunto(s)
Antígenos Helmínticos/inmunología , Proteínas de Unión al Calcio/inmunología , Complemento C1q/inmunología , Integrinas/inmunología , Necator americanus/inmunología , Ribonucleoproteínas/inmunología , Animales , Anticuerpos Antihelmínticos/inmunología , Especificidad de Anticuerpos , Antígenos Helmínticos/genética , Antígenos Helmínticos/aislamiento & purificación , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/aislamiento & purificación , Calreticulina , Cricetinae , Citoplasma , Perfilación de la Expresión Génica , Hemólisis/inmunología , Humanos , Señales de Clasificación de Proteína , Conejos , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Proteínas Recombinantes de Fusión/aislamiento & purificación , Ribonucleoproteínas/genética , Ribonucleoproteínas/aislamiento & purificación , Solubilidad , Resonancia por Plasmón de Superficie/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA